Tunisia Pharmaceuticals and Healthcare Report Q4 2017

BMI Industry View

Table: Headline Pharmaceuticals & Healthcare Forecasts (Tunisia) (2015-2021)

SWOT

Industry Forecast

Pharmaceutical Market Forecast

Table: Pharmaceutical Sales, Historical Data And Forecasts (Tunisia 2013-2021)

Healthcare Market Forecast

Table: Healthcare Expenditure Trends, Historical Data And Forecasts (2013-2021)

Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Tunisia 2013-2021)

Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Tunisia 2013-2021)

Industry Risk/Reward Index

MENA Pharmaceuticals & Healthcare Risk/Reward Index

Regulatory Development

Regulatory Review

Pricing And Reimbursement Regime

Market Overview

Healthcare Sector

Research & Development

Clinical Trials

Epidemiology

Competitive Landscape

Research-Based Industry

Generic Drugmakers

Demographic Forecast

Table: Population Headline Indicators (Tunisia 1990-2025)

Table: Key Population Ratios (Tunisia 1990-2025)

Table: Urban/Rural Population & Life Expectancy (Tunisia 1990-2025)

Table: Population By Age Group (Tunisia 1990-2025)

Table: Population By Age Group % (Tunisia 1990-2025)

Glossary

Methodology

Pharmaceutical Expenditure Forecast Model

Healthcare Expenditure Forecast Model

Notes On Methodology

Risk/Reward Index Methodology

Table: Indicators - Rationale And Sources

Tunisia Pharmaceuticals and Healthcare Report Q4 2017

BMI View: Tunisia's pharmaceutical market will continue to be met with challenges that ensuremultinational drugmakers remain wary of significant investment plans. A progressively improving businessclimate is having a notable impact on developments within the pharmaceutical sector and wider economy;however, the actual benefits will take time to materialise. Crucially, higher growth opportunities willpresent themselves within the generic medicines sector, while the high industry-associated risk profile willdeter any significant investment by multinational firms.

Headline Expenditure Projections

Pharmaceuticals: TND1.95bn (USD909mn) in 2016 to TND2.14bn (USD895mn) in 2017; +9.6%growth in local currency terms and -1.4% in US dollar terms.

Healthcare: TND6.5bn (USD3.0bn) in 2016 to TND6.9 (USD2.9bn) in 2017; +6.0% growth in localcurrency terms and -4.7% in US dollar terms.

Latest Updates

Merck KGaA announced in July 2017 that it plans to roll out an innovative healthcare initiative inTunisia by 2019 - following its launch in Kenya in 2016.